← Open Payments lookup

DANIEL PINA: Open Payments

NPI 1720479884 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$944 in 49 payments from 13 companies in 2025. Trend: 2023 $1,508 · 2024 $842 · 2025 $944

Food & beverage: $944
CompanyPaymentsAmount
Novo Nordisk Inc18$196
AstraZeneca Pharmaceuticals LP4$185
ABBVIE INC.5$98
Otsuka America Pharmaceutical, Inc.4$95
Abbott Laboratories3$86
Lilly USA, LLC4$75
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
GlaxoSmithKline, LLC.2$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$29
PFIZER INC.1$23

Products named: FARXIGA, JARDIANCE, REXULTI, LINZESS, Rybelsus, Ozempic, PROCLAIM, Wegovy.

Industry payments across TX — which companies pay providers there.